 |
PDS Biotechnology Welcomes Matthew Hill as Chief Financial OfficerPDS Biotechnology announced that Matthew Hill will join PDS Biotech as its Chief Financial Officer (CFO) effective as of October 18, 2021, to lead the company’s financial strategy through its next phase of growth Research, News & Market Data on PDS Biotech |
 |
ACCO Brands Corporation Announces Third Quarter 2021 Earnings WebcastACCO Brands Corporation announced that it will release its third quarter 2021 earnings after the market close on October 26, 2021 Research, News & Market Data on ACCO Brands |
 |
Voyager Digital Business Update for the Quarter Ended September 30, 2021Voyager Digital announced preliminary revenue and user metrics for the fiscal 2022 first quarter ended September 30, 2021 Research, News & Market Data on Voyager Digital |
 |
Cocrystal Pharma Receives Australian Regulatory Clearance to Initiate Phase 1 Study of CC-42344 for the Treatment of Pandemic and Seasonal InfluenzaCocrystal Pharma announced receipt of clearance from an Australian Human Research Ethics Committee (HREC) to initiate a Phase 1 trial with its orally administered PB2 inhibitor CC-42344 for the treatment of pandemic and seasonal influenza A Research, News & Market Data on Cocrystal Pharma |
Stay up to date. Follow us:
|